{
  "guideline": {
    "id": "PA166104990",
    "name": "Annotation of DPWG Guideline for voriconazole and CYP2C19",
    "source": "DPWG",
    "version": 25,
    "url": "https://www.pharmgkb.org/guidelineAnnotation/PA166104990",
    "relatedChemicals": [
      {
        "id": "PA10233",
        "name": "voriconazole",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA124",
        "name": "cytochrome P450 family 2 subfamily C member 19",
        "symbol": "CYP2C19"
      }
    ],
    "recommendation": true,
    "guidelineGenes": [
      {
        "alleles": [
          {
            "id": 1451417480,
            "_label": "*1",
            "function": {
              "term": "Normal function",
              "termId": "haplotypeTags:1445558335"
            }
          },
          {
            "id": 1451417481,
            "_label": "*2",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417482,
            "_label": "*3",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417483,
            "_label": "*4",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417484,
            "_label": "*5",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417485,
            "_label": "*6",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417486,
            "_label": "*7",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417487,
            "_label": "*8",
            "function": {
              "term": "No function",
              "termId": "haplotypeTags:1445558515"
            }
          },
          {
            "id": 1451417488,
            "_label": "*9",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451417489,
            "_label": "*10",
            "function": {
              "term": "Decreased function",
              "termId": "haplotypeTags:1445558331"
            }
          },
          {
            "id": 1451417490,
            "_label": "*17",
            "function": {
              "term": "Increased function",
              "termId": "haplotypeTags:1445558332"
            }
          }
        ],
        "gene": {
          "chr": {
            "id": "PA504",
            "name": "chr10",
            "symbol": null
          },
          "strand": "plus",
          "id": "PA124",
          "name": "cytochrome P450 family 2 subfamily C member 19",
          "symbol": "CYP2C19"
        }
      }
    ]
  },
  "annotationGroups": [
    {
      "id": "PA166240491",
      "name": "NM",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "CYP2C19:Increased function/Normal function",
        "CYP2C19:Normal function/Normal function"
      ],
      "metabolizerStatus": {
        "id": 1451417556,
        "html": "<p>Normal Metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451417557,
        "html": "<p>The guideline does not provide a recommendation for voriconazole in normal metabolizers.</p>\n"
      },
      "implications": {
        "id": 1451417555,
        "html": "<p>The guideline does not provide a description of the impact of a normal metabolizer phenotype on voriconazole.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166240504",
      "name": "IM",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "No",
        "termId": "rxChange:1448602495"
      },
      "genePhenotypes": [
        "CYP2C19:Decreased function/Increased function",
        "CYP2C19:Decreased function/Normal function",
        "CYP2C19:Increased function/No function",
        "CYP2C19:No function/Normal function"
      ],
      "metabolizerStatus": {
        "id": 1451417571,
        "html": "<p>Intermediate Metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451417572,
        "html": "<p>Monitor the plasma concentration.</p>\n"
      },
      "implications": {
        "id": 1451417570,
        "html": "<p>The gene variation can reduce the conversion of voriconazole and consequently increase the plasma concentration. This could result in improved efficacy or an increase in the risk of side effects.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166240490",
      "name": "UM",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "Yes",
        "termId": "rxChange:1448602497"
      },
      "genePhenotypes": [
        "CYP2C19:Increased function/Increased function"
      ],
      "metabolizerStatus": {
        "id": 1451838221,
        "html": "<p>Ultrarapid Metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451838222,
        "html": "<p>Use an initial dose that is 1.5x higher and monitor the plasma concentration.</p>\n"
      },
      "implications": {
        "id": 1451838220,
        "html": "<p>The gene variation increases the conversion of voriconazole, which increases the risk of ineffectiveness.</p>\n"
      },
      "activityScore": null
    },
    {
      "id": "PA166240503",
      "name": "PM",
      "strength": {
        "term": "N/A",
        "termId": "guidelineStrength:981501929"
      },
      "rxChangeStatus": {
        "term": "Yes",
        "termId": "rxChange:1448602497"
      },
      "genePhenotypes": [
        "CYP2C19:Decreased function/Decreased function",
        "CYP2C19:Decreased function/No function",
        "CYP2C19:No function/No function"
      ],
      "metabolizerStatus": {
        "id": 1451838241,
        "html": "<p>Poor Metabolizer</p>\n"
      },
      "recommendation": {
        "id": 1451838242,
        "html": "<p>Use 50% of the standard dose and monitor the plasma concentration.</p>\n"
      },
      "implications": {
        "id": 1451838240,
        "html": "<p>The gene variation can reduce the conversion of voriconazole and consequently increase the plasma concentration. This could result in improved efficacy or an increase in the risk of side effects. Initially, the risk of side effects is of particular interest.</p>\n"
      },
      "activityScore": null
    }
  ],
  "citations": [
    {
      "pmid": "21412232",
      "title": "Pharmacogenetics: from bench to byte--an update of guidelines.",
      "authors": [
        "Swen J J",
        "Nijenhuis M",
        "de Boer A",
        "Grandia L",
        "Maitland-van der Zee A H",
        "Mulder H",
        "Rongen G A P J M",
        "van Schaik R H N",
        "Schalekamp T",
        "Touw D J",
        "van der Weide J",
        "Wilffert B",
        "Deneer V H M",
        "Guchelaar H-J"
      ],
      "journal": "Clinical pharmacology and therapeutics",
      "year": 2011
    }
  ],
  "version": "2022-10-08-09-34"
}